CSO Hergen Spits

About Aimm Therapeutics
CSO Hergen Spits

Management

CSO Hergen Spits, PhD

A founder of AIMM, Hergen Spits has served as the CSO since the company’s inception. Bringing 35 years of career experience spanning both academia and industry, Spits is a professor of Cell Biology at the Academic Medical Center of the University of Amsterdam where he leads a research program investigating autoimmune- and inflammatory disease. Spits previously served as a senior director at Genentech guiding drug discovery for cancer immunotherapy and heading up the autoimmune disease program.